Alaethes Wealth’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $424K | Hold |
5,110
| – | – | 0.13% | 90 |
|
|
2025
Q1 | $414K | Hold |
5,110
| – | – | 0.15% | 92 |
|
|
2024
Q4 | $460K | Sell |
5,110
-20
| -0.4% | -$1.8K | 0.16% | 91 |
|
|
2024
Q3 | $507K | Sell |
5,130
-460
| -8% | -$45.4K | 0.19% | 91 |
|
|
2024
Q2 | $518K | Sell |
5,590
-290
| -5% | -$26.9K | 0.21% | 88 |
|
|
2024
Q1 | $558K | Sell |
5,880
-20
| -0.3% | -$1.9K | 0.24% | 91 |
|
|
2023
Q4 | $527K | Sell |
5,900
-885
| -13% | -$79K | 0.25% | 93 |
|
|
2023
Q3 | $495K | Hold |
6,785
| – | – | 0.27% | 91 |
|
|
2023
Q2 | $565K | Hold |
6,785
| – | – | 0.31% | 89 |
|
|
2023
Q1 | $517K | Hold |
6,785
| – | – | 0.3% | 90 |
|
|
2022
Q4 | $563K | Buy |
6,785
+375
| +6% | +$31.1K | 0.39% | 81 |
|
|
2022
Q3 | $508K | Sell |
6,410
-10
| -0.2% | -$793 | 0.37% | 84 |
|
|
2022
Q2 | $477K | Sell |
6,420
-525
| -8% | -$39K | 0.35% | 84 |
|
|
2022
Q1 | $624K | Sell |
6,945
-125
| -2% | -$11.2K | 0.4% | 81 |
|
|
2021
Q4 | $792K | Hold |
7,070
| – | – | 0.5% | 77 |
|
|
2021
Q3 | $889K | Hold |
7,070
| – | – | 0.65% | 64 |
|
|
2021
Q2 | $957K | Sell |
7,070
-10
| -0.1% | -$1.35K | 0.74% | 52 |
|
|
2021
Q1 | $960K | Buy |
+7,080
| New | +$960K | 0.89% | 40 |
|